RXI PHARMACEUTICALS CORP (RXII) analyst actions
Rating and price-target actions on RXII in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RXII overview →
No RXII analyst action events in the measured window.
Nothing matched in the current window — the RXII overview has every event we measure for this name.
Get an email when RXII moves on news →Keep exploring
More RXII: earnings → · SEC filings → · RXII overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AKERS BIOSCIENCES INC COMMON S (AKER) | 478 | -0.87% | 33% |
| Axon Enterprise, Inc. (AXON) | 478 | -0.04% | 48% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 477 | -0.11% | 46% |
| Ascendis Pharma A/S - Ordinary Share (ASND) | 474 | -0.08% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.